<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35627278</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">893</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes13050893</ELocationID><Abstract><AbstractText><i>Serine palmitoyltransferase long chain base subunit 1</i> (<i>SPTLC1</i>) encodes a serine palmitoyltransferase (SPT) resident in the endoplasmic reticulum (ER). Pathological <i>SPTLC1</i> variants cause a form of hereditary sensory and autonomic neuropathy (HSAN1A), and have recently been linked to unrestrained sphingoid base synthesis, causing a monogenic form of amyotrophic lateral sclerosis (ALS). It was postulated that the phenotypes associated with dominant variants in <i>SPTLC1</i> may represent a continuum between neuropathy and ALS in some cases, complicated by additional symptoms such as cognitive impairment. A biochemical explanation for this clinical observation does not exist. By performing proteomic profiling on immortalized lymphoblastoid cells derived from one patient harbouring an alanine to serine amino acid substitution at position 20, we identified a subset of dysregulated proteins playing significant roles in neuronal homeostasis and might have a potential impact on the manifestation of symptoms. Notably, the identified p.(A20S)-SPTLC1 variant is associated with decrease of transcript and protein level. Moreover, we describe associated muscle pathology findings, including signs of mild inflammation accompanied by dysregulation of respective markers on both the protein and transcript levels. By performing coherent anti-Stokes Raman scattering microscopy, presence of protein and lipid aggregates could be excluded.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>K&#xf6;lbel</LastName><ForeName>Heike</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9629-7053</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, Center for Translational Neuro- and Behavioral Sciences, University Clinic Essen, University of Duisburg-Essen, 45122 Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kraft</LastName><ForeName>Florian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5324-9155</Identifier><AffiliationInfo><Affiliation>Institute of Human Genetics, Medical Faculty, RWTH Aachen University, 52062 Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hentschel</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Leibniz-Institut f&#xfc;r Analytische Wissenschaften-ISAS-e.V., 44139 Dortmund, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Czech</LastName><ForeName>Artur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Leibniz-Institut f&#xfc;r Analytische Wissenschaften-ISAS-e.V., 44139 Dortmund, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangfuss</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9975-0092</Identifier><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, Center for Translational Neuro- and Behavioral Sciences, University Clinic Essen, University of Duisburg-Essen, 45122 Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohassel</LastName><ForeName>Payam</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5313-9514</Identifier><AffiliationInfo><Affiliation>Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Dr., Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Chi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Leibniz-Institut f&#xfc;r Analytische Wissenschaften-ISAS-e.V., 44139 Dortmund, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stenzel</LastName><ForeName>Werner</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schara-Schmidt</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, Center for Translational Neuro- and Behavioral Sciences, University Clinic Essen, University of Duisburg-Essen, 45122 Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preu&#xdf;e</LastName><ForeName>Corinna</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, 10117 Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology with Institute for Translational Neurology, University Hospital M&#xfc;nster, 48149 M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roos</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Center for Neuromuscular Disorders in Children and Adolescents, Center for Translational Neuro- and Behavioral Sciences, University Clinic Essen, University of Duisburg-Essen, 45122 Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Heimer Institute for Muscle Research, University Hospital Bergmannsheil, Ruhr-University Bochum, 44789 Bochum, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.3.1.50</RegistryNumber><NameOfSubstance UI="C487784">SPTLC1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.50</RegistryNumber><NameOfSubstance UI="D051102">Serine C-Palmitoyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073659" MajorTopicYN="Y">Gain of Function Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051102" MajorTopicYN="Y">Serine C-Palmitoyltransferase</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">HSAN1A</Keyword><Keyword MajorTopicYN="N">SPTLC1</Keyword><Keyword MajorTopicYN="N">juvenile ALS</Keyword><Keyword MajorTopicYN="N">proteomic profiling</Keyword><Keyword MajorTopicYN="N">serine palmitoyltransferase</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35627278</ArticleId><ArticleId IdType="pmc">PMC9140917</ArticleId><ArticleId IdType="doi">10.3390/genes13050893</ArticleId><ArticleId IdType="pii">genes13050893</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Han G., Gupta S.D., Gable K., Niranjanakumari S., Moitra P., Eichler F., Brown R.H., Jr., Harmon J.M., Dunn T.M. Identification of small subunits of mammalian serine palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc. Natl. Acad. Sci. USA. 2009;106:8186&#x2013;8191. doi: 10.1073/pnas.0811269106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0811269106</ArticleId><ArticleId IdType="pmc">PMC2688822</ArticleId><ArticleId IdType="pubmed">19416851</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers S.J., Malladi C.S., Hyland R.A., Bautista T., Boadle R., Robinson P.J., Nicholson G.A. Mutations in the SPTLC1 protein cause mitochondrial structural abnormalities and endoplasmic reticulum stress in lymphoblasts. DNA Cell Biol. 2014;33:399&#x2013;407. doi: 10.1089/dna.2013.2182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/dna.2013.2182</ArticleId><ArticleId IdType="pubmed">24673574</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer-Grumbach M., De Jonghe P., Verhoeven K., Timmerman V., Wagner K., Hartung H.P., Nicholson G.A. Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: A review. Arch. Neurol. 2003;60:329&#x2013;334. doi: 10.1001/archneur.60.3.329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.60.3.329</ArticleId><ArticleId IdType="pubmed">12633143</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson G.A. SPTLC1-Related Hereditary Sensory Neuropathy. In: Adam M.P., Ardinger H.H., Pagon R.A., Wallace S.E., Bean L.J.H., Gripp K.W., Mirzaa G.M., Amemiya A., editors. GeneReviews&#xae;. University of Washington; Seattle, WA, USA: 1993.</Citation><ArticleIdList><ArticleId IdType="pubmed">20301564</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings M.J., Lochm&#xfc;ller A., Atalaia A., Horvath R. Targeted Therapies for Hereditary Peripheral Neuropathies: Systematic Review and Steps Towards a &#x2018;treatabolome&#x2019;. J. Neuromuscul. Dis. 2021;8:383&#x2013;400. doi: 10.3233/JND-200546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-200546</ArticleId><ArticleId IdType="pmc">PMC8203235</ArticleId><ArticleId IdType="pubmed">32773395</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohassel P., Donkervoort S., Lone M.A., Nalls M., Gable K., Gupta S.D., Foley A.R., Hu Y., Saute J.A.M., Moreira A.L., et al. Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. Nat. Med. 2021;27:1197&#x2013;1204. doi: 10.1038/s41591-021-01346-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01346-1</ArticleId><ArticleId IdType="pubmed">34059824</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Chia R., Miller D.E., Li R., Kumaran R., Abramzon Y., Alahmady N., Renton A.E., Topp S.D., Gibbs J.R., et al. Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis. JAMA Neurol. 2021;78:1236&#x2013;1248. doi: 10.1001/jamaneurol.2021.2598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.2598</ArticleId><ArticleId IdType="pmc">PMC8406220</ArticleId><ArticleId IdType="pubmed">34459874</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhart J.M., Schumbrutzki C., Wortelkamp S., Sickmann A., Zahedi R.P. Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J. Proteom. 2012;75:1454&#x2013;1462. doi: 10.1016/j.jprot.2011.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2011.11.016</ArticleId><ArticleId IdType="pubmed">22166745</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D.W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1&#x2013;13. doi: 10.1093/nar/gkn923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn923</ArticleId><ArticleId IdType="pmc">PMC2615629</ArticleId><ArticleId IdType="pubmed">19033363</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009;4:44&#x2013;57. doi: 10.1038/nprot.2008.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.211</ArticleId><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;lbel H., Preu&#xdf;e C., Brand L., von Moers A., Della Marina A., Schuelke M., Roos A., Goebel H.H., Schara-Schmidt U., Stenzel W. Inflammation, fibrosis and skeletal muscle regeneration in LGMDR9 are orchestrated by macrophages. Neuropathol. Appl. Neurobiol. 2021;47:856&#x2013;866. doi: 10.1111/nan.12730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12730</ArticleId><ArticleId IdType="pubmed">33973272</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos A., Preusse C., Hathazi D., Goebel H.H., Stenzel W. Proteomic Profiling Unravels a Key Role of Specific Macrophage Subtypes in Sporadic Inclusion Body Myositis. Front. Immunol. 2019;10:1040. doi: 10.3389/fimmu.2019.01040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01040</ArticleId><ArticleId IdType="pmc">PMC6522546</ArticleId><ArticleId IdType="pubmed">31143183</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentschel A., Czech A., M&#xfc;nchberg U., Freier E., Schara-Schmidt U., Sickmann A., Reimann J., Roos A. Protein signature of human skin fibroblasts allows the study of the molecular etiology of rare neurological diseases. Orphanet J. Rare Dis. 2021;16:73. doi: 10.1186/s13023-020-01669-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-020-01669-1</ArticleId><ArticleId IdType="pmc">PMC7874489</ArticleId><ArticleId IdType="pubmed">33563298</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;pf A., Johnson K., Bates A., Phillips L., Chao K.R., England E.M., Laricchia K.M., Mullen T., Valkanas E., Xu L., et al. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness. Genet. Med. Off. J. Am. Coll. Med. Genet. 2020;22:1478&#x2013;1488. doi: 10.1038/s41436-020-0840-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-0840-3</ArticleId><ArticleId IdType="pmc">PMC7462745</ArticleId><ArticleId IdType="pubmed">32528171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollipara L., Buchkremer S., Coraspe J.A.G., Hathazi D., Senderek J., Weis J., Zahedi R.P., Roos A. In-depth phenotyping of lymphoblastoid cells suggests selective cellular vulnerability in Marinesco-Sj&#xf6;gren syndrome. Oncotarget. 2017;8:68493&#x2013;68516. doi: 10.18632/oncotarget.19663.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.19663</ArticleId><ArticleId IdType="pmc">PMC5620273</ArticleId><ArticleId IdType="pubmed">28978133</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall L.L., Stimpson S.E., Hyland R., Coorssen J.R., Myers S.J. Increased lipid droplet accumulation associated with a peripheral sensory neuropathy. J. Chem. Biol. 2014;7:67&#x2013;76. doi: 10.1007/s12154-014-0108-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12154-014-0108-y</ArticleId><ArticleId IdType="pmc">PMC3976696</ArticleId><ArticleId IdType="pubmed">24711860</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinia H.A., Burger K.N., Bonn M., M&#xfc;ller M. Quantitative label-free imaging of lipid composition and packing of individual cellular lipid droplets using multiplex CARS microscopy. Biophys. J. 2008;95:4908&#x2013;4914. doi: 10.1529/biophysj.108.137737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.108.137737</ArticleId><ArticleId IdType="pmc">PMC2576358</ArticleId><ArticleId IdType="pubmed">18689461</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J.X., Xie X.S. Vibrational spectroscopic imaging of living systems: An emerging platform for biology and medicine. Science. 2015;350:aaa8870. doi: 10.1126/science.aaa8870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa8870</ArticleId><ArticleId IdType="pubmed">26612955</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Kooi A.J., Ginjaar H.B., Busch H.F., Wokke J.H., Barth P.G., de Visser M. Limb girdle muscular dystrophy: A pathological and immunohistochemical reevaluation. Muscle Nerve. 1998;21:584&#x2013;590. doi: 10.1002/(SICI)1097-4598(199805)21:5&lt;584::AID-MUS4&gt;3.0.CO;2-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1097-4598(199805)21:5&lt;584::AID-MUS4&gt;3.0.CO;2-4</ArticleId><ArticleId IdType="pubmed">9572237</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadeau A., Kinali M., Main M., Jimenez-Mallebrera C., Aloysius A., Clement E., North B., Manzur A.Y., Robb S.A., Mercuri E., et al. Natural history of Ullrich congenital muscular dystrophy. Neurology. 2009;73:25&#x2013;31. doi: 10.1212/WNL.0b013e3181aae851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181aae851</ArticleId><ArticleId IdType="pubmed">19564581</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos A., Thompson R., Horvath R., Lochm&#xfc;ller H., Sickmann A. Intersection of Proteomics and Genomics to &#x201c;Solve the Unsolved&#x201d; in Rare Disorders such as Neurodegenerative and Neuromuscular Diseases. Proteom. Clin. Appl. 2018;12:1700073. doi: 10.1002/prca.201700073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.201700073</ArticleId><ArticleId IdType="pubmed">29059504</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson R., Spendiff S., Roos A., Bourque P.R., Warman Chardon J., Kirschner J., Horvath R., Lochm&#xfc;ller H. Advances in the diagnosis of inherited neuromuscular diseases and implications for therapy development. Lancet Neurol. 2020;19:522&#x2013;532. doi: 10.1016/S1474-4422(20)30028-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30028-4</ArticleId><ArticleId IdType="pubmed">32470424</ArticleId></ArticleIdList></Reference><Reference><Citation>Juneja M., Azmi A., Baets J., Roos A., Jennings M.J., Saveri P., Pisciotta C., Bernard-Marissal N., Schneider B.L., Verfaillie C., et al. PFN2 and GAMT as common molecular determinants of axonal Charcot-Marie-Tooth disease. J. Neurol. Neurosurg. Psychiatry. 2018;89:870&#x2013;878. doi: 10.1136/jnnp-2017-317562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317562</ArticleId><ArticleId IdType="pubmed">29449460</ArticleId></ArticleIdList></Reference><Reference><Citation>Auer-Grumbach M., Bode H., Pieber T.R., Schabh&#xfc;ttl M., Fischer D., Seidl R., Graf E., Wieland T., Schuh R., Vacariu G., et al. Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype. Eur. J. Med. Genet. 2013;56:266&#x2013;269. doi: 10.1016/j.ejmg.2013.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2013.02.002</ArticleId><ArticleId IdType="pmc">PMC3682180</ArticleId><ArticleId IdType="pubmed">23454272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurklinsky S., Chen J., McNiven M.A. Growth cone morphology and spreading are regulated by a dynamin-cortactin complex at point contacts in hippocampal neurons. J. Neurochem. 2011;117:48&#x2013;60. doi: 10.1111/j.1471-4159.2011.07169.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07169.x</ArticleId><ArticleId IdType="pmc">PMC3278041</ArticleId><ArticleId IdType="pubmed">21210813</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung G., Kim E.J., Cicvaric A., Sase S., Gr&#xf6;ger M., H&#xf6;ger H., Sialana F.J., Berger J., Monje F.J., Lubec G. Drebrin depletion alters neurotransmitter receptor levels in protein complexes, dendritic spine morphogenesis and memory-related synaptic plasticity in the mouse hippocampus. J. Neurochem. 2015;134:327&#x2013;339. doi: 10.1111/jnc.13119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13119</ArticleId><ArticleId IdType="pubmed">25865831</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz R., Berberich S., Rathgeber L., Kolleker A., K&#xf6;hr G., Kornau H.C. AMPA receptor signaling through BRAG2 and Arf6 critical for long-term synaptic depression. Neuron. 2010;66:768&#x2013;780. doi: 10.1016/j.neuron.2010.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.05.003</ArticleId><ArticleId IdType="pubmed">20547133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedeschi V., Petrozziello T., Secondo A. Ca2+ dysregulation in the pathogenesis of amyotrophic lateral sclerosis. Int. Rev. Cell Mol. Biol. 2021;363:21&#x2013;47. doi: 10.1016/bs.ircmb.2021.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.ircmb.2021.02.014</ArticleId><ArticleId IdType="pubmed">34392931</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory J.M., Livesey M.R., McDade K., Selvaraj B.T., Barton S.K., Chandran S., Smith C. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain. J. Pathol. 2020;250:67&#x2013;78. doi: 10.1002/path.5351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5351</ArticleId><ArticleId IdType="pmc">PMC6973025</ArticleId><ArticleId IdType="pubmed">31579943</ArticleId></ArticleIdList></Reference><Reference><Citation>Rico B., Beggs H.E., Schahin-Reed D., Kimes N., Schmidt A., Reichardt L.F. Control of axonal branching and synapse formation by focal adhesion kinase. Nat. Neurosci. 2004;7:1059&#x2013;1069. doi: 10.1038/nn1317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1317</ArticleId><ArticleId IdType="pmc">PMC2711902</ArticleId><ArticleId IdType="pubmed">15378065</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu H., Xu C., Zhang W., Liu Q., Rondard P., Pin J.P., Liu J. GABAB receptor activation protects neurons from apoptosis via IGF-1 receptor transactivation. J. Neurosci. Off. J. Soc. Neurosci. 2010;30:749&#x2013;759. doi: 10.1523/JNEUROSCI.2343-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2343-09.2010</ArticleId><ArticleId IdType="pmc">PMC6633015</ArticleId><ArticleId IdType="pubmed">20071540</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira A.S., Santiago F.E., Balioni L.F., Ferrari Mde F., Almeida M.C., Carrettiero D.C. BAG2 expression dictates a functional intracellular switch between the p38-dependent effects of nicotine on tau phosphorylation levels via the &#x3b1;7 nicotinic receptor. Pt 1Exp. Neurol. 2016;275:69&#x2013;77. doi: 10.1016/j.expneurol.2015.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.10.005</ArticleId><ArticleId IdType="pubmed">26496817</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu D., Hage A., Don-Carolis K., Huang E., Joselin A., Safarpour F., Marcogliese P.C., Rousseaux M.W., Hewitt S.J., Huang T., et al. BAG2 Gene-mediated Regulation of PINK1 Protein Is Critical for Mitochondrial Translocation of PARKIN and Neuronal Survival. J. Biol. Chem. 2015;290:30441&#x2013;30452. doi: 10.1074/jbc.M115.677815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.677815</ArticleId><ArticleId IdType="pmc">PMC4683266</ArticleId><ArticleId IdType="pubmed">26538564</ArticleId></ArticleIdList></Reference><Reference><Citation>Stimpson S.E., Coorssen J.R., Myers S.J. Mitochondrial protein alterations in a familial peripheral neuropathy caused by the V144D amino acid mutation in the sphingolipid protein, SPTLC1. J. Chem. Biol. 2015;8:25&#x2013;35. doi: 10.1007/s12154-014-0125-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12154-014-0125-x</ArticleId><ArticleId IdType="pmc">PMC4286568</ArticleId><ArticleId IdType="pubmed">25584079</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H., Schneider M., Williamson D.B., Ito A., Takeuchi M., Handford P.A., Haltiwanger R.S. Two novel protein O-glucosyltransferases that modify sites distinct from POGLUT1 and affect Notch trafficking and signaling. Proc. Natl. Acad. Sci. USA. 2018;115:E8395&#x2013;E8402. doi: 10.1073/pnas.1804005115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1804005115</ArticleId><ArticleId IdType="pmc">PMC6130362</ArticleId><ArticleId IdType="pubmed">30127001</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui M., Ying R., Jiang X., Li G., Zhang X., Zheng J., Tam K.Y., Liang B., Shi A., G&#xf6;bel V., et al. A Model of Hereditary Sensory and Autonomic Neuropathy Type 1 Reveals a Role of Glycosphingolipids in Neuronal Polarity. J. Neurosci. Off. J. Soc. Neurosci. 2019;39:5816&#x2013;5834. doi: 10.1523/JNEUROSCI.2541-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2541-18.2019</ArticleId><ArticleId IdType="pmc">PMC6636076</ArticleId><ArticleId IdType="pubmed">31138658</ArticleId></ArticleIdList></Reference><Reference><Citation>Epand R.M., Kam A., Bridgelal N., Saiga A., Topham M.K. The alpha isoform of diacylglycerol kinase exhibits arachidonoyl specificity with alkylacylglycerol. Biochemistry. 2004;43:14778&#x2013;14783. doi: 10.1021/bi0484724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0484724</ArticleId><ArticleId IdType="pubmed">15544348</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung M., Shulga Y.V., Ivanova P.T., Myers D.S., Milne S.B., Brown H.A., Topham M.K., Epand R.M. Diacylglycerol kinase epsilon is selective for both acyl chains of phosphatidic acid or diacylglycerol. J. Biol. Chem. 2009;284:31062&#x2013;31073. doi: 10.1074/jbc.M109.050617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.050617</ArticleId><ArticleId IdType="pmc">PMC2781506</ArticleId><ArticleId IdType="pubmed">19744926</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulga Y.V., Topham M.K., Epand R.M. Substrate specificity of diacylglycerol kinase-epsilon and the phosphatidylinositol cycle. FEBS Lett. 2011;585:4025&#x2013;4028. doi: 10.1016/j.febslet.2011.11.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.11.016</ArticleId><ArticleId IdType="pmc">PMC3237191</ArticleId><ArticleId IdType="pubmed">22108654</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulga Y.V., Topham M.K., Epand R.M. Study of arachidonoyl specificity in two enzymes of the PI cycle. J. Mol. Biol. 2011;409:101&#x2013;112. doi: 10.1016/j.jmb.2011.03.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.03.071</ArticleId><ArticleId IdType="pmc">PMC3095698</ArticleId><ArticleId IdType="pubmed">21477596</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato M., Liu K., Sasaki S., Kunii N., Sakai H., Mizuno H., Saga H., Sakane F. Evaluations of the selectivities of the diacylglycerol kinase inhibitors R59022 and R59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method. Pharmacology. 2013;92:99&#x2013;107. doi: 10.1159/000351849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351849</ArticleId><ArticleId IdType="pubmed">23949095</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevinsky C.J., Khan F., Kokabee L., Darehshouri A., Maddipati K.R., Conklin D.S. NDRG1 regulates neutral lipid metabolism in breast cancer cells. Breast Cancer Res. 2018;20:55. doi: 10.1186/s13058-018-0980-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13058-018-0980-4</ArticleId><ArticleId IdType="pmc">PMC6001025</ArticleId><ArticleId IdType="pubmed">29898756</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L.X., Liu G.L., Liu Z.J., Lu C., Wu Z.Y. Identification and functional characterization of two missense mutations in NDRG1 associated with Charcot-Marie-Tooth disease type 4D. Hum. Mutat. 2017;38:1569&#x2013;1578. doi: 10.1002/humu.23309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23309</ArticleId><ArticleId IdType="pubmed">28776325</ArticleId></ArticleIdList></Reference><Reference><Citation>Gantner M.L., Eade K., Wallace M., Handzlik M.K., Fallon R., Trombley J., Bonelli R., Giles S., Harkins-Perry S., Heeren T.F.C., et al. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy. N. Engl. J. Med. 2019;381:1422&#x2013;1433. doi: 10.1056/NEJMoa1815111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1815111</ArticleId><ArticleId IdType="pmc">PMC7685488</ArticleId><ArticleId IdType="pubmed">31509666</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Xue P., Chen H., Yuan M., Kang Y., Duscher D., Machens H.G., Chen Z. Denervation drives skeletal muscle atrophy and induces mitochondrial dysfunction, mitophagy and apoptosis via miR-142a-5p/MFN1 axis. Theranostics. 2020;10:1415&#x2013;1432. doi: 10.7150/thno.40857.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.40857</ArticleId><ArticleId IdType="pmc">PMC6956801</ArticleId><ArticleId IdType="pubmed">31938072</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S. Muscle fiber type diversity revealed by anti-myosin heavy chain antibodies. FEBS J. 2018;285:3688&#x2013;3694. doi: 10.1111/febs.14502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14502</ArticleId><ArticleId IdType="pubmed">29761627</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens L., Bastide B., Maurage C.A., Dupont E., Montel V., Cieniewski-Bernard C., Cuisset J.M., Vall&#xe9;e L., Mounier Y. Childhood spinal muscular atrophy induces alterations in contractile and regulatory protein isoform expressions. Neuropathol. Appl. Neurobiol. 2008;34:659&#x2013;670. doi: 10.1111/j.1365-2990.2008.00950.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2008.00950.x</ArticleId><ArticleId IdType="pubmed">18363640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon M.S., Wosiski-Kuhn M., Gillespie R., Caress J., Milligan C. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve. 2019;59:10&#x2013;22. doi: 10.1002/mus.26289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26289</ArticleId><ArticleId IdType="pubmed">29979464</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham Z.A., Gallagher P.M., Cardozo C.P. Focal adhesion kinase and its role in skeletal muscle. J. Muscle Res. Cell Motil. 2015;36:305&#x2013;315. doi: 10.1007/s10974-015-9415-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10974-015-9415-3</ArticleId><ArticleId IdType="pmc">PMC4659753</ArticleId><ArticleId IdType="pubmed">26142360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kathiriya J.J., Nakra N., Nixon J., Patel P.S., Vaghasiya V., Alhassani A., Tian Z., Allen-Gipson D., Dav&#xe9; V. Galectin-1 inhibition attenuates profibrotic signaling in hypoxia-induced pulmonary fibrosis. Cell Death Discov. 2017;3:17010. doi: 10.1038/cddiscovery.2017.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddiscovery.2017.10</ArticleId><ArticleId IdType="pmc">PMC5385413</ArticleId><ArticleId IdType="pubmed">28417017</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>